Literature DB >> 27052184

Acute Renal Failure in Different Malignant Tumors.

Sanja Radojevic-Skodric1, Ljiljana Bogdanovic, Milena Jovanovic, Ivana Baralic, Zoran Dzamic, Ron Gordon, Simona Ognjanovic, Gordana Basta-Jovanovic.   

Abstract

Acute renal failure (ARF) represents a severe complication of malignancies, that causes significant morbidity and mortality. ARF is a common part of multiple organ dysfunction in critically ill patients with cancer with reported mortality rates from 72% to 85% in patients who need renal replacement therapy. The pathways leading to ARF in cancer patients are common to the development of ARF in other conditions. However, certain factors leading to the development of ARF may be associated to the tumor or to the tumor therapy. The purpose of this review is to give specific aspects of renal disease in critically ill cancer patients (CICPs), to overview the causes of ARF in CICPs and to describe recent progress in the management of these complications, including treatment toxicity and bone marrow transplantation (BMT). The prevention of ARF is obligatory and therefore the possible treatments of ARF in CICPs are also discussed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27052184     DOI: 10.2174/0929867323666160407113245

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  1 in total

1.  Analysis of the association between resolution of disseminated intravascular coagulation (DIC) and treatment outcomes in post-marketing surveillance of thrombomodulin alpha for DIC with infectious disease and with hematological malignancy by organ failure.

Authors:  Noriaki Kawano; Hideo Wada; Toshimasa Uchiyama; Kazuo Kawasugi; Seiji Madoiwa; Naoki Takezako; Kei Suzuki; Yoshinobu Seki; Takayuki Ikezoe; Tsuyoshi Hattori; Kohji Okamoto
Journal:  Thromb J       Date:  2020-02-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.